Supernus Pharmaceuticals Inc (SUPN) President, CEO Jack A. Khattar Bought $190,008 of SharesGuruFocus • 08/27/19
Supernus Pharmaceuticals: Anti-CGRPs Are Causing Migraines For This Biotech But Investors Are Too Pessimistic Creating A Compelling OpportunitySeeking Alpha • 08/14/19
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19
4 Medical Stocks to Consider After Federal Judge Blocks Trump ProposalZacks Investment Research • 07/11/19
Supernus Pharmaceuticals (SUPN) CEO, Jack Khattar on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/08/19
Supernus Pharmaceuticals (SUPN) Lags Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/07/19